Search Results

open access

Medicare: Beneficiary Cost-Sharing Under Prescription Drug Legislation

Description: This report provides an analysis of how the cost-sharing and premium provisions under the Prescription Drug and Medicare Improvement Act of 2003 (S. 1) and the Medicare Prescription Drug and Modernization Act of 2003 (H bill would affect the amount that a beneficiary would pay annually for prescription drugs.
Date: July 25, 2003
Creator: Peterson, Chris L.
Partner: UNT Libraries Government Documents Department
open access

Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Description: This report examines these proposals as well as the “Medicare Rx Drug Benefit and Discount Act of 2003,” which was introduced by Representative Charles Rangel, the ranking member of the House Ways and Means Committee. Specifically, this report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs.
Date: June 17, 2003
Creator: Peterson, Chris L.
Partner: UNT Libraries Government Documents Department
open access

Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Description: This report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plans.
Date: June 26, 2003
Creator: Peterson, Chris L.
Partner: UNT Libraries Government Documents Department
open access

Medicare Prescription Drug and Reform Legislation

Description: This report describes the major features of S. 1, as ordered reported, and the measure to be considered by the House Ways and Means Committee, H.R. 2473, as ordered reported.
Date: June 19, 2003
Creator: O'Sullivan, Jennifer; Chaikind, Hinda Ripps; Tilson, Sibyl L.; Boulanger, Jennifer & Morgan, Paulette C.
Partner: UNT Libraries Government Documents Department
open access

Tobacco Price Support: An Overview of the Program

Description: Over 93% of U.S. tobacco production is flue-cured and burley (both being cigarette tobacco types). These crops are particularly important to the agriculture of North Carolina (where flue-cured is grown) and Kentucky (where burley is grown). Together, these two states produce 65% of the total U.S. tobacco crop. The federal tobacco price support program is designed to support and stabilize prices for farmers. It operates through a combination of mandatory marketing quotas and nonrecourse loans. M… more
Date: July 6, 1998
Creator: Womach, Jasper
Partner: UNT Libraries Government Documents Department
open access

Tobacco-Related Programs and Activities of the U.S. Department of Agriculture: Operation and Cost

Description: The U.S. Department of Agriculture (USDA) has long operated programs that directly assist farmers and others with the production and marketing of numerous crops, including tobacco. In most cases, the programs themselves are not controversial. Increasingly, however, where tobacco is involved, the use of federal funds is being called into question.
Date: July 6, 1998
Creator: Womach, Jasper
Partner: UNT Libraries Government Documents Department
open access

Tobacco Control: Enforcement and Effectiveness of Federal and State Youth Access Laws

Description: This report reviews recent efforts to limit youth access to cigarettes through enforcement of federal and state laws prohibiting tobacco sales to minors. Under the federal Synar Amendment, states must conduct compliance checks and enforce their minimum age-of-sale laws or risk losing block grant funds
Date: August 19, 1998
Creator: Redhead, C. Stephen & Austin-Lane, Joy
Partner: UNT Libraries Government Documents Department
open access

Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Description: Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an under… more
Date: June 19, 2000
Creator: Schacht, Wendy H.
Partner: UNT Libraries Government Documents Department
Back to Top of Screen